High-Dose Vitamin C Doubles Pancreatic Cancer Patient Survival Rates: Clinical Trial

Life expectancy with chemotherapy alone is eight months, while adding high-dose intravenous vitamin C resulted in 16 months of survival.
High-Dose Vitamin C Doubles Pancreatic Cancer Patient Survival Rates: Clinical Trial
Capture_The_World/Shutterstock
|Updated:
0:00

Adding high-dose vitamin C to a cancer treatment regimen may double survival time, according to a clinical trial that tested this in pancreatic cancer patients.

Typically diagnosed in its advanced stages, pancreatic cancer has a poor prognosis and leaves patients with limited treatment options, with most surviving only eight months with standard chemotherapy.

Cara Michelle Miller
Cara Michelle Miller
Author
Cara Michelle Miller is a freelance writer and holistic health educator. She taught at the Pacific College of Health and Science in NYC for 12 years and led communication seminars for engineering students at The Cooper Union. She now writes articles with a focus on integrative care and holistic modalities.